跳至主要内容
临床试验/NCT04239781
NCT04239781Unknown不适用

A Questionnaire Survey for Factors That Influence Postoperative Treatment Decision-making in Patients With Hepatocellular Carcinoma

Shanghai Zhongshan Hospital1 个研究点 分布在 1 个国家目标入组 2,500 人开始时间: 2020年1月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
2,500
试验地点
1
主要终点
HCC patients' willingness and expectation for post-operative treatment.

研究概览

简要总结

This is a non-interventional and questionnaire survey study. The investigators try to find out patient's willingness and expectation for post-operative treatments for hepatocellular carcinoma (HCC), as well as patients' willingness to participate in clinical trials using a questionnaire. The ultimate goal is to assist physicians in clinical treatment decision, clinical research, and government health and economic decision-making, as well as to help investigators understand how to increase public awareness of the HCC and the treatment course and efficacy of HCC, and the awareness of clinical trials.

详细描述

There is no world widely accepted adjuvant therapy for HCC and the guidelines from AASLD or EASL did not recommend any adjuvant therapy to prevent postoperative tumor recurrence of HCC. The goal of an adjuvant therapy is to meet the requirements of patients, which are influenced by many factors such as the strength of doctors' recommendation, economic affordability, tolerance of adverse reactions to treatment, and expectation of efficacy. Therefore, understanding patients' expectations for an adjuvant therapy after surgery will help doctors give more reasonable treatment. Participating in clinical trials is a new process of understanding and acceptance for each patient, so investigators try to understand the willingness and ideas of patients to participate in clinical trials, so as to provide more information for designing clinical trials and recruiting subjects for clinical trials.

The research was conducted through face-to-face interview, WeChat and telephone interview. For face-to-face interview and WeChat to participants, an informed consent should be signed.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female aged 18 years or older;
  • Confirmed diagnosis of HCC histologically or clinically;
  • The participant must have received surgical resection;
  • Ability to complete the questionnaire or independently or with the help of a friend, relative, or staff member of the oncology department.

排除标准

  • The patients that researchers consider not suitable to participate in this study.

结局指标

主要结局

HCC patients' willingness and expectation for post-operative treatment.

时间窗: 6 months

Use questionnaires to understand the willingness and expectation of patients for post-operative treatment of hepatocellular carcinoma, as well as their willingness to participate in clinical trials.

次要结局

未报告次要终点

研究者

发起方
Shanghai Zhongshan Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hui-Chuan Sun

Professor of Surgery

Shanghai Zhongshan Hospital

研究点 (1)

Loading locations...

相似试验